| [1] LIN L, NI B, LIN H, et al.Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review[J]. J Ethnopharmacol, 2015,159: 158-183. [2] SONG L, WANG Q, BI YN, et al.Study on liver and kidney toxicity of 4 components of Polygoni Multifori radix on mice after intragastric administration for 14 days[J]. Chin J Pharmacov, 2018, 15(9): 513-517.
 [3] Center for Drug Reevaluation, NMPA. The UK MHRA warns of liver damage associated with polygonum multiflorum[J]. Chin J Pharmacov, 2006, 3(5): 313-314.
 [4] WANG Q, YANG JB, WANG Y, et al.Effects of Polygonum multiflorum extract on rat kidneys based on transporters[J]. Chin J Pharmacov,2022,19(6): 626-629.
 [5] WANG Q, WEN HR, YANG JB, et al.Study on the components of Polygonum multiflorum aqueous extract in rats after long-term administration[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 620-625.
 [6] WANG Q, ZHANG QH, WEN HR, et al.Study on potential hepatotoxicity of main monomers of Polygonum multiflorum based on liver micro-tissue[J]. Chin J Chin Mater Med, 2020, 45(12): 2954-2959.
 [7] Chinese Pharmacopoeia Commission.Pharmacopoeia of People’s Republic of China. Volume I(中华人民共和国药典一部,2020年版)[M]. Beijing: China Medical Science Press, 2020.
 [8] LUO DQ, LIU Y, WANG GH, et al.Quality analysis of Polygonum multiflorum and its preparation[J]. Journal of Chinese Medicinal Materials,2016, 39(10):2422-2425.
 [9] DAN M, LIU D, HUANG SJ, et al.Study the hepatotoxicity of monoanthranone with emodin-type using in vitro 3D liver model[J]. Chin J New Drug, 2019, 28(11):1312-1317.
 [10] WANG Q, WANG YD, YANG JB, et al.Study on hepatotoxicity of emodin-8-O-β-D- glucoside and its metabolites[J]. Chin J New Drug, 2020, 29(16):1856-1862.
 [11] National Toxicology Program.NTP toxicology and carcinogenesis studies of emodin (CAS NO. 518-82-1) feed studies in F344/N rats and B6C3F1 mice[J]. Natl Toxicol Program Tech Rep Ser,2001, 493:1-278.
 [12] HUO GT, WANG YN, LYU JJ, et al.Chronic toxicity study of emodin monomer in Kunming mice by ig administration[J].Drug Eval Res, 2021, 44(7):1425-1433.
 [13] FENG X, FANG SN, GAO YX, et al.Current research situation of nephrotoxicity of Chinese herbal medicine[J]. Chin J Chin Mater Med, 2018, 43(3): 417-424.
 [14] WEN HR, YAN YJ, SONG J, et al.Study on in vitro and in vivo genotoxicity of emodin-8-O-β-D-glucoside[J]. China Pharmacy, 2020, 31(1):18-13.
 [15] LI KM, SUN XC.Collection and analysis of the data of plants containing emodin-8-O-β-D-glucopyranoside in China[J]. Chin J New Drug, 2016, 25(24): 2787-2792.
 [16] MU MJ, LI Y, LI CG, et al.Simultaneous determination of two anthraquinone glucosides in polygonum multiflorum based on UPLC[J]. J Dali Univ, 2018, 36(12): 57-61.
 [17] ZHANG LY, JIANG ZZ, PU CH, et al.Six-month oral toxicity study of total anthraquinone in radix et rhizoma rhei in SD rats[J]. Chin J Biochem Pharm, 2004, 24(4): 206-209.
 [18] HUANG WY, LI YQ, JIANG Q, et al.Apoptosis mechanism of emodin on renal toxicity in mice[J].Chin J Exp Tradit Med Form, 2019, 25(11): 42-47.
 [19] LI YQ, HUANG WY, LIANG YS, et al.Mechanism of nephrotoxicity of aloe emodin in mice[J]. Chin J Exp Tradit Med Form, 2019, 25(11): 48-53.
 [20] HU YF, HUANG WY, LI YQ, et al.Mechanism of rhein on renal toxicity of mice[J]. Chin J Exp Tradit Med Form, 2019, 25(11): 54-59.
 [21] FRAZIER KS, SEELY JC, HARD GC, et al.Proliferative and nonproliferative lesions of the rat and mouse urinary system[J]. Toxicol Pathol, 2012, 40(4 Suppl): 14S-86S.
 [22] YANG JB, TIAN JY, DAI Z, et al.α-Glucosidase inhibitors extracted from the roots of Polygonummu ltiflorum Thunb.[J]. Fitoterapia, 2017,117: 65-70.
 [23] YANG JB, WANG Q, WANG XT, et al.Difference analysis of chemical composition of Polygoni Multiflori Radix and Polygoni Multiflori Radix preparata based on plant metabonomics[J]. Chin J Pharmacov, 2022, 19(6): 615-619
 [24] YANG JB, LI WF, LIU Y, et al.Acute toxicity screening of different extractions, components and constituents of Polygonum multiflorum thunb. on zebrafish (danio rerio) embryos in vivo[J]. Biomed Pharmacother, 2018, 99: 205-213.
 [25] LI HY, YANG JB, LI WF, et al.In vivo hepatotoxicity screening of different extracts, components, and constituents of Polygoni multiflori Thunb. in zebrafish (danio rerio) larvae[J]. Biomed Pharmacother, 2020, 131: 110524.
 [26] LOCATELLI M, EPIFANO F, GENOVESE S, et al.Anthraquinone profile, antioxidant and antimicrobial properties of bark extracts of Rhamnus catharticus and R. orbiculatus[J]. Nat Prod Commun, 2011, 6(9):1275-1280
 [27] PAN XP, WANG C, ZHANG T.Physcion synergistically enhances the cytotoxicity of sorafenib in hepatocellular carcinoma[J]. Anat Rec (Hoboken), 2019, 302(12): 2171-2177.
 [28] ZHANG LY, SU WH, XIONG Y, et al.Protective effect of physcione on acute liver in rats[J]. Chin J Prim Med Pharm, 2007, 12(14): 2014-2015.
 [29] WANG RJ, YANG Y, BAI T.Effect of physcion on SIRT1-AMPK pathway in alcoholic liver injury[J]. Chin Pharmacol Bull, 2020, 36(11):1557-1562.
 [30] LI JF, WANG RJ, ZHANG YX, et al.Effect of physcion on alleviating drug-induced liver injury through HMGB1- NLRP3 signaling pathway[J]. China Tradit Herb Drugs, 2022, 53(7): 2095-2102.
 [31] THOMAS J, ZIMMERMAN B, HARDISTY JF.Occurrence of spontaneous amphophilic-vacuolar renal tubule tumors in Sprague-Dawley rats from subchronic toxicity studies[J]. Toxicol Pathol, 2013, 41(6): 866-871.
 [32] HARD GC, SEELY JC, KISSLING GE, et al.Spontaneous occurrence of a distinctive renal tubule tumor phenotype in rat carcinogenicity studies conducted by the national toxicology program[J]. Toxicol Pathol, 2008,36(3):388-396.
 [33] ADLEY BP, SMITH ND, NAYAR R, et al.Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations[J]. Arch Pathol Lab Med, 2006,130(12):1865-1870.
 |